Getting Started with GLP-1 Therapy Ready to begin
Cardiovascular Outcomes TRIUMPH-Outcomes (NCT06383390), enrolling approximately 10,000 participants with established cardiovascular disease, won't report until 20282029
The press release notes that in an OASIS 4 trial, participants taking the oral semaglutide of 25 mg saw a 16.6 percent mean weight loss while "treatment was adhered to." Why It Matters Until now, the most widely used GLP-1 medicines for weight loss have been injections
Wegovy influences our digestive hormones but it's possible that it also affects the balance of bacteria in the gut
It is essential to follow manufacturer instructions and consult a healthcare professional before starting supplementation, particularly if you have existing health conditions or take prescribed medications
In older adults, the risk of falls and frailty is increased 6